Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -7.52%10.46B | -1.02%24.27B | -6.41%11.31B | 14.12%24.52B | 13.50%12.08B | -22.94%21.48B | -22.12%10.65B | 9.93%27.88B | 9.76%13.67B | -10.04%25.36B |
| Operating income | -7.52%10.46B | -1.02%24.27B | -6.41%11.31B | 14.12%24.52B | 13.50%12.08B | -22.94%21.48B | -22.12%10.65B | 9.93%27.88B | 9.76%13.67B | -10.04%25.36B |
| Cost of sales | 10.48%-6.28B | 1.53%-15.28B | 8.33%-7.02B | -19.15%-15.52B | -26.74%-7.65B | 25.28%-13.02B | 30.00%-6.04B | -11.51%-17.43B | -12.34%-8.63B | 13.29%-15.63B |
| Operating expenses | 10.48%-6.28B | 1.53%-15.28B | 8.33%-7.02B | -19.15%-15.52B | -26.74%-7.65B | 25.28%-13.02B | 30.00%-6.04B | -11.51%-17.43B | -12.34%-8.63B | 13.29%-15.63B |
| Gross profit | -2.68%4.18B | -0.13%8.99B | -3.09%4.29B | 6.38%9B | -3.85%4.43B | -19.03%8.46B | -8.62%4.61B | 7.40%10.45B | 5.60%5.04B | -4.30%9.73B |
| Administrative expenses | 7.60%-1.16B | 7.44%-3.07B | 2.84%-1.25B | -11.57%-3.32B | 2.85%-1.29B | 5.86%-2.97B | -8.66%-1.33B | -25.03%-3.16B | -26.04%-1.22B | -1.06%-2.53B |
| Special items of operating profit | -172.40%-296.73M | -66.96%317.5M | -28.37%409.84M | 777.98%960.9M | 237.89%572.19M | -109.84%-141.73M | -147.44%-414.95M | 85.93%1.44B | 99.72%874.67M | -44.10%774.41M |
| Operating profit | -21.04%2.73B | -6.14%6.24B | -7.07%3.45B | 24.29%6.64B | 29.57%3.71B | -38.77%5.35B | -38.97%2.87B | 9.44%8.73B | 10.65%4.7B | -11.87%7.98B |
| Financing cost | 23.86%-1.19B | 5.23%-3.09B | -1.49%-1.57B | -18.76%-3.26B | -8.38%-1.54B | -0.99%-2.75B | -4.92%-1.42B | -6.65%-2.72B | -4.22%-1.36B | -4.78%-2.55B |
| Share of profits of associates | 245.03%57.85M | -42.57%48.15M | -73.35%16.77M | -19.92%83.85M | -55.96%62.92M | 80.32%104.71M | -12.96%142.87M | -82.44%58.07M | -17.62%164.14M | -14.08%330.78M |
| Share of profit from joint venture company | -7.24%285.72M | -6.43%525.1M | 12.10%308.04M | 0.08%561.18M | -23.10%274.79M | -34.93%560.75M | 38.38%357.36M | 18.09%861.71M | -23.82%258.25M | 32.33%729.68M |
| Earning before tax | -15.11%1.88B | -7.68%3.72B | -11.90%2.21B | 23.37%4.03B | 29.12%2.51B | -52.89%3.27B | -48.35%1.94B | 6.83%6.93B | 8.08%3.76B | -14.12%6.49B |
| Tax | 7.59%-409.43M | 15.77%-812.08M | 19.72%-443.04M | -3.64%-964.11M | -3.07%-551.87M | 36.47%-930.29M | 20.83%-535.41M | -17.26%-1.46B | 4.70%-676.3M | 27.13%-1.25B |
| After-tax profit from continuing operations | -16.99%1.47B | -5.14%2.91B | -9.70%1.77B | 31.22%3.06B | 39.03%1.96B | -57.29%2.34B | -54.38%1.41B | 4.34%5.47B | 11.35%3.09B | -10.30%5.24B |
| Earning after tax | -16.99%1.47B | -5.14%2.91B | -9.70%1.77B | 31.22%3.06B | 39.03%1.96B | -57.29%2.34B | -54.38%1.41B | 4.34%5.47B | 11.35%3.09B | -10.30%5.24B |
| Minority profit | -11.94%508.58M | 1.81%1.1B | 6.57%577.55M | 1.40%1.08B | -17.72%541.94M | 0.05%1.06B | 22.05%658.7M | 28.56%1.06B | 38.94%539.68M | 20.95%824.9M |
| Special items of profit attributable to shareholders | -9.36%61.77M | 44.39%133.79M | 48.31%68.15M | 0.01%92.66M | -16.99%45.95M | -56.19%92.65M | -56.02%55.36M | -8.92%211.47M | 9.64%125.87M | -1.13%232.18M |
| Profit attributable to shareholders | -20.05%897.09M | -11.50%1.68B | -18.08%1.12B | 60.46%1.9B | 97.36%1.37B | -71.84%1.18B | -71.33%694.03M | 0.30%4.2B | 6.72%2.42B | -15.07%4.18B |
| Basic earnings per share | -21.20%0.084 | -14.31%0.1563 | -20.86%0.1066 | 60.99%0.1824 | 102.86%0.1347 | -72.65%0.1133 | -72.34%0.0664 | -0.36%0.4142 | 6.05%0.2401 | -16.48%0.4157 |
| Diluted earnings per share | -21.20%0.084 | -14.17%0.1563 | -20.74%0.1066 | 61.01%0.1821 | 103.48%0.1345 | -72.53%0.1131 | -72.26%0.0661 | 0.02%0.4117 | 6.38%0.2383 | -16.07%0.4116 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Ernst & Young Accounting Firm | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.